OAM
MBIO icon

Oxford Asset Management’s Mustang Bio MBIO Stock Holding History

Oxford Asset Management’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$77K Sell
38
-264
-87% -$677K 0.01% 155
2019
Q4 		$925K Buy
302
+243
+412% +$556K 0.03% 910
2019
Q3 		$143K Buy
59
+43
+269% +$118K ﹤0.01% 1608
2019
Q2 		$43K Buy
+16
New +$45.7K ﹤0.01% 1642

Other funds holding MBIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Oxford Asset Management's MBIO Position: Q1 2020 in Review

Oxford Asset Management reduced its Mustang Bio (MBIO) stake by 87% in Q1 2020, selling an estimated $677K and leaving 38 shares worth $77K. The position accounts for 0.01% of the portfolio, ranked #155.

Oxford Asset Management first reported a position in MBIO in Q2 2019 and has held it in 4 quarters since. The position peaked at $925K in Q4 2019. 64 funds tracked by Wall St. Rank hold MBIO as of Q1 2020.

  • Oxford Asset Management held 38 shares of Mustang Bio worth $77K as of Q1 2020.
  • Oxford Asset Management sold 264 Mustang Bio shares in Q1 2020, an estimated $677K.
  • Mustang Bio made up 0.01% of Oxford Asset Management's portfolio in Q1 2020, its #155 holding.
  • Oxford Asset Management first reported a position in Mustang Bio in Q2 2019 and has held it in 4 quarters since.
  • Oxford Asset Management's Mustang Bio position peaked at $925K in Q4 2019.
  • 64 funds tracked by Wall St. Rank held Mustang Bio as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.